相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort
Grigoris Effraimidis et al.
JOURNAL OF MEDICAL GENETICS (2021)
Nationwide screening for Fabry disease in unselected stroke patients
Ales Tomek et al.
PLOS ONE (2021)
Hearing loss in Fabry disease: A 16 year follow-up study of the Danish nationwide cohort
Puriya Daniel Wurtz Yazdanfard et al.
MOLECULAR GENETICS AND METABOLISM (2021)
The benefits and challenges of family genetic testing in rare genetic diseases - lessons from Fabry disease
Dominique P. Germain et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2021)
X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis
Emanuela Viggiano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease
Daniel G. Bichet et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2021)
The Right Not to Know: some Steps towards a Compromise
Ben Davies et al.
ETHICAL THEORY AND MORAL PRACTICE (2021)
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts
Dominique P. Germain et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 30-month results from the randomized phase 3 ATTRACT study
Ulla Feldt-Rasmussen et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Age-related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study
Christoffer V. Madsen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment
Puriya Daniel Yazdanfard et al.
PLOS ONE (2019)
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Derralynn A. Hughes et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)
Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy
Martin S. Maron et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature
Megan C. Roberts et al.
HEALTH AFFAIRS (2018)
Fabry Disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995-2017
Dana Doheny et al.
JOURNAL OF MEDICAL GENETICS (2018)
The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease in 2 Danish families
Ulla Feldt-Rasmussen et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortiz et al.
MOLECULAR GENETICS AND METABOLISM (2018)
European expert consensus statement on therapeutic goals in Fabry disease
Christoph Wanner et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study
Christoffer Valdorff Madsen et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2017)
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
Alberto Ortiz et al.
JOURNAL OF MEDICAL GENETICS (2016)
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
D. P. Germain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
Dominique P. Germain et al.
JOURNAL OF MEDICAL GENETICS (2015)
Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-Up
Kirsten Korsholm et al.
PLOS ONE (2015)
Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement
Hans C. Fledelius et al.
ACTA OPHTHALMOLOGICA (2015)
Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease
Turid Apelland et al.
HEART (2014)
A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
L. van der Tol et al.
JOURNAL OF MEDICAL GENETICS (2014)
Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease
Thaneas Prabakaran et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Fabry disease in children: agalsidase-beta enzyme replacement therapy
L. Borgwardt et al.
CLINICAL GENETICS (2013)
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation
David G. Warnock et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Detection of Large Gene Rearrangements in X-linked Genes by Dosage Analysis: Identification of Novel α-Galactosidase A (GLA) Deletions Causing Fabry Disease
Robert Dobrovolny et al.
HUMAN MUTATION (2011)
Diagnostic dilemma: A young woman with Fabry disease symptoms no family history, and a sequencing cryptic α-galactosidase a large deletion
Ulla Feldt-Rasmussen et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Receptor-Mediated Endocytosis of α-Galactosidase A in Human Podocytes in Fabry Disease
Thaneas Prabakaran et al.
PLOS ONE (2011)
An example of rapid prenatal diagnosis of Fabry's disease usingmicrotechniques
H. Galjaard et al.
CLINICAL GENETICS (2010)
Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women
Ole Havndrup et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry
Stephen Waldek et al.
GENETICS IN MEDICINE (2009)
Autonomic skin responses in females with Fabry disease
Anette T. Moller et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2009)
Functional and structural nerve fiber findings in heterozygote patients with Fabry disease
Anette Torvin Moller et al.
PAIN (2009)
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
William R. Wilcox et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry
C. M. Eng et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Small-fibre neuropathy in female Fabry patients:: reduced allodynia and skin blood flow after topical capsaicin
Anette T. Moller et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2006)
The pattern of inheritance of X-linked traits is not dominant or recessive, just X-linked
WB Dobyns
ACTA PAEDIATRICA (2006)
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
Christine M. Eng et al.
GENETICS IN MEDICINE (2006)
Relationship between X-inactivation and clinical involvement in Fabry heterozygotes.: Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population
R Dobrovolny et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Fabry disease:: a new challenge in endocrinology and metabolism?
U Feldt-Rasmussen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
分享论文
